CPC B01L 3/502738 (2013.01) [B01L 3/50273 (2013.01); B01L 3/502715 (2013.01); B01L 7/52 (2013.01); B01L 13/02 (2019.08); C12N 13/00 (2013.01); C12N 15/1013 (2013.01); C12Q 1/6844 (2013.01); G01N 1/286 (2013.01); G01N 1/34 (2013.01); G01N 21/6486 (2013.01); B01L 2200/10 (2013.01); B01L 2200/141 (2013.01); B01L 2300/041 (2013.01); B01L 2300/06 (2013.01); B01L 2300/0627 (2013.01); B01L 2300/0681 (2013.01); B01L 2300/0861 (2013.01); B01L 2300/123 (2013.01); B01L 2300/14 (2013.01); B01L 2300/1805 (2013.01); B01L 2400/0487 (2013.01); B01L 2400/06 (2013.01); G01N 2001/2866 (2013.01)] | 13 Claims |
1. A nucleic acid analysis device, comprising:
a stage on which a cartridge is mountable, wherein the cartridge comprises a plurality of chambers for extracting nucleic acids from a sample including a pretreatment chamber in which the sample is crushed and subject to homogenization, cell disruption, and purification;
a nucleic acid extraction unit performing a nucleic acid extraction and a nucleic acid amplification through crushing of the sample, the cell disruption, and the nucleic acid purification by applying a magnetic field to the cartridge, the nucleic acid extraction unit comprising:
a pump driving unit for applying a pressure required for fluid movements between chambers of the cartridge; and
a control unit controlling the stage and the nucleic acid extraction unit so that the nucleic acid extraction and the nucleic acid amplification through the crushing of the sample, the cell disruption, and the nucleic acid purification are collectively performed.
|